Showing results (21-30 of 229) with videos related to
Sort By:
Pageof 23
Journal of Cellular Biochemistry|January 10, 2003
Synthetic LXXLL peptide antagonize 1,25-dihydroxyvitamin D3-dependent transcriptionJ Wesley Pike, Peterman Pathrose, Olga Barmina, et al.The Prostate|December 16, 2017
Validation of histone deacetylase 3 as a therapeutic target in castration-resistant prostate cancerAbigail B McLeod, James P Stice, Suzanne E Wardell, et al.Endocrine-Related Cancer|April 27, 2017
Impact of 27-hydroxylase (CYP27A1) and 27-hydroxycholesterol in breast cancerSiker Kimbung, Ching-Yi Chang, Pär-Ola Bendahl, et al.Biochemical and Biophysical Research Communications|February 27, 2004
Selective LXXLL peptides antagonize transcriptional activation by the retinoid-related orphan receptor RORgammaShogo Kurebayashi, Takeshi Nakajima, Seong-Chul Kim, et al.Cancer Immunology Research|October 27, 2022
Increased CaMKK2 Expression Is an Adaptive Response That Maintains the Fitness of Tumor-Infiltrating Natural Killer CellsPatrick K Juras, Luigi Racioppi, Debarati Mukherjee, et al.Proceedings of the National Academy of Sciences of the United States of America|March 24, 2026
Bert W. O'Malley (1936-2025): A great scientist, mentor, and proud IrishmanDonald P McDonnellClinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
The molecular pharmacology of estrogen receptor modulators: implications for the treatment of breast cancerDonald P McDonnellMaturitas|September 1, 2004
The molecular determinants of estrogen receptor pharmacologyDonald P McDonnellProceedings of the National Academy of Sciences of the United States of America|March 11, 2026
Bert W. O'Malley (1936-2025): A great scientist, mentor, and proud IrishmanDonald P McDonnellCancer Research|November 1, 2008
Estrogen-related receptor alpha is critical for the growth of estrogen receptor-negative breast cancerRebecca A Stein, Ching-Yi Chang, Dmitri A Kazmin, et al.Pageof 23